Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Keefe, Bruyette & Woods reiterated its Market Perform rating on American Financial Group, Inc. (NYSE:AFG) on August 11, 2026.
Read moreCitigroup reiterated its Neutral rating on Healthpeak Properties, Inc. (NYSE:DOC) on August 11, 2026.
Read moreTD Cowen reiterated its Buy rating on Cheniere Energy, Inc. (NYSE:LNG) on August 11, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Block, Inc. (OTC:BSQKZ) on August 11, 2026.
Read moreKeefe, Bruyette & Woods reiterated its Outperform rating on American International Group, Inc. (NYSE:AIG) on August 11, 2026.
Read moreJP Morgan reiterated its Neutral rating on CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) on August 11, 2026.
Read moreOppenheimer reiterated its Outperform rating on Target Corporation (NYSE:TGT) on August 11, 2026.
Read moreBMO Capital reiterated its Market Perform rating on Target Corporation (NYSE:TGT) on August 11, 2026.
Read moreBarclays reiterated its Underweight rating on W.W. Grainger, Inc.
Read moreBNP Paribas reiterated its Outperform rating on Zoetis Inc. (NYSE:ZTS) on August 11, 2026.
Read moreCitigroup reiterated its Buy rating on Zoetis Inc. (NYSE:ZTS) on August 11, 2026.
Read moreGoldman Sachs analysts upgraded Autodesk, Inc. (NASDAQ:ADSK) from Sell to Neutral on August 11, 2026.
Read moreKeefe, Bruyette & Woods reiterated its Outperform rating on MetLife, Inc. (NYSE:MET) on August 11, 2026.
Read moreJP Morgan reiterated its Overweight rating on MetLife, Inc. (NYSE:MET) on August 11, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on United Rentals, Inc. (NYSE:URI) on August 11, 2026.
Read moreLake Street reiterated its Buy rating on Fluent, Inc. (NASDAQ:FLNT) on August 11, 2026.
Read moreCanaccord Genuity reiterated its Hold rating on Fluent, Inc. (NASDAQ:FLNT) on August 11, 2026.
Read moreEvercore ISI Group analysts downgraded Tenax Therapeutics, Inc. (NASDAQ:TENX) from Outperform to In-Line on August 11, 2026.
Read moreChardan Capital analysts downgraded Tenax Therapeutics, Inc. (NASDAQ:TENX) from Buy to Neutral on August 11, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Tenax Therapeutics, Inc. (NASDAQ:TENX) on August 11, 2026.
Read more
